Angiogenesis in cutaneous lesions of leprosy: implications for treatment

Arch Dermatol. 2007 Dec;143(12):1527-9. doi: 10.1001/archderm.143.12.1527.

Abstract

Objective: To examine the potential role of angiogenesis in leprosy.

Design: Immunohistochemical analysis of leprosy lesions.

Setting: Department of Dermatology, Venereology, and Leprology, Kasturba Medical College; Division of Dermatology, University of California at Los Angeles; and Departments of Dermatology and Pathology, Emory University.

Patients: Thirty-two cutaneous lesions that represented the spectrum of leprosy were obtained from 32 patients.

Main outcome measure: CD31 microvessel counts.

Results: The mean CD31 microvessel count in borderline tuberculoid, midborderline, and lepromatous leprosy lesions was significantly higher than in indeterminate leprosy lesions.

Conclusions: Increased bacterial load is associated with increased angiogenesis. Angiogenesis inhibitors may be of benefit in the treatment of leprosy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Blood Vessels / metabolism
  • Blood Vessels / pathology
  • Humans
  • Immunohistochemistry
  • Leprosy / complications*
  • Leprosy / drug therapy
  • Leprosy, Borderline / complications
  • Leprosy, Lepromatous / complications
  • Leprosy, Tuberculoid / complications
  • Microcirculation
  • Neovascularization, Pathologic / etiology*
  • Neovascularization, Pathologic / metabolism
  • Neovascularization, Pathologic / pathology
  • Neovascularization, Pathologic / prevention & control
  • Platelet Endothelial Cell Adhesion Molecule-1 / metabolism
  • Skin / blood supply*

Substances

  • Angiogenesis Inhibitors
  • Platelet Endothelial Cell Adhesion Molecule-1